-+ 0.00%
-+ 0.00%
-+ 0.00%

Brown Forman (BF.B) Stock Looks Like A Bargain On A 57% Slump

Simply Wall St·09/18/2026 12:29:02
語音播報

Brown-Forman has seen its stock lose ground over the past few years, which naturally pushes investors to ask whether the current share price still lines up with the cash the business can generate over time. After a long stretch of weaker returns, the key issue now is how that market value stacks up against what a cash flow based valuation suggests.

  • Over the past 5 years, Brown-Forman shares have declined 56.6%, which puts real pressure on the question of whether the current market value reflects what its future cash flows might be worth.
  • The group’s long established spirits portfolio and brand driven model can shape expectations for steady cash generation. This matters a lot when you try to price those streams through a Discounted Cash Flow (DCF) lens.
  • What if you looked at Brown-Forman through its earnings instead? See why Brown-Forman's 16.9x P/E tells a different valuation story.

The issue now is whether Brown-Forman’s current share price is adequately explained by the cash flows that a Discounted Cash Flow (DCF) estimate points to.

If you are weighing Brown-Forman through the lens of its cash flows, it can help to compare that picture with a wider group of companies screened for 29 high quality undervalued stocks.

Is Brown-Forman Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model here is built around what Brown-Forman can earn for shareholders in the future rather than where the share price has been. On the cash side, the business produced about $860.7 million of free cash flow over the latest twelve months, which gives the model a solid starting base instead of a speculative turnaround story.

Projected free cash flows in the coming years are set at a level that implies growing rather than shrinking cash generation, then taper into more modest increases as the company matures. Those estimates feed into a 2 Stage Free Cash Flow to Equity framework that points to an intrinsic value that the model suggests is substantially above the current trading price of $26.50. That gap reflects the market putting a lower value on Brown-Forman’s steady cash profile than the cash flow projections imply. Find out what Brown-Forman could be worth using our Discounted Cash Flow (DCF) estimate.

The Brown-Forman Narrative: What Would Justify Today's Price?

Simply Wall St Narratives take the Brown-Forman valuation puzzle and spell out what would need to happen to growth, margins and earnings for the shares to look meaningfully higher or lower than today’s price. Each narrative links a fair value to a particular storyline about Brown-Forman’s possible catalysts and key risks, so you can track which version of events appears to be unfolding over time on the Community page.

Brown-Forman splits opinion, with one camp seeing room for upside and another arguing the shares lean rich once category and cost risks are fully weighed.

Bull case: 5% undervalued

"Brown-Forman is realizing strong organic net sales growth in emerging international markets (25%+ in some regions like Brazil and Mexico)..."

Discover why this Narrative puts Brown-Forman at 5% undervalued.

Bear case: 30% overvalued

"Ongoing shifts in consumer preferences due to rising health consciousness and increased moderation, particularly among younger demographics, are expected to drive sustained declines in alcohol consumption..."

Explore why this Narrative puts Brown-Forman at 30% overvalued.

Before you act on Brown-Forman's valuation, there is one more factor to check

The figures only tell part of the story, because the people steering Brown-Forman and the way their rewards line up with your interests can tilt the whole risk and return profile. See who runs Brown-Forman and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.